• Je něco špatně v tomto záznamu ?

Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing

Z. Chyra Kufova, T. Sevcikova, J. Januska, P. Vojta, A. Boday, P. Vanickova, J. Filipova, K. Growkova, T. Jelinek, M. Hajduch, R. Hajek,

. 2018 ; 71 (8) : 687-694. [pub] 20180217

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18033305

Grantová podpora
NV15-29667A MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek

E-zdroje Online Plný text

NLK ProQuest Central od 2000-01-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2000-01-01 do Před 6 měsíci

AIMS: Amyloidosis is caused by deposition of abnormal protein fibrils, leading to damage of organ function. Hereditary amyloidosis represents a monogenic disease caused by germline mutations in 11 amyloidogenic precursor protein genes. One of the important but non-specific symptoms of amyloidosis is hypertrophic cardiomyopathy. Diagnostics of hereditary amyloidosis is complicated and the real cause can remain overlooked. We aimed to design hereditary amyloidosis gene panel and to introduce new next-generation sequencing (NGS) approach to investigate hereditary amyloidosis in a cohort of patients with hypertrophic cardiomyopathy of unknown significance. METHODS: Design of target enrichment DNA library preparation using Haloplex Custom Kit containing 11 amyloidogenic genes was followed by MiSeq Illumina sequencing and bioinformatics identification of germline variants using tool VarScan in a cohort of 40 patients. RESULTS: We present design of NGS panel for 11 genes (TTR, FGA, APOA1, APOA2, LYZ, GSN, CST3, PRNP, APP, B2M, ITM2B) connected to various forms of amyloidosis. We detected one mutation, which is responsible for hereditary amyloidosis. Some other single nucleotide variants are so far undescribed or rare variants or represent common polymorphisms in European population. CONCLUSIONS: We report one positive case of hereditary amyloidosis in a cohort of patients with hypertrophic cardiomyopathy of unknown significance and set up first panel for NGS in hereditary amyloidosis. This work may facilitate successful implementation of the NGS method by other researchers or clinicians and may improve the diagnostic process after validation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033305
003      
CZ-PrNML
005      
20240725141657.0
007      
ta
008      
181008s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/jclinpath-2017-204978 $2 doi
035    __
$a (PubMed)29455155
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Chyra Kufova, Zuzana $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
245    10
$a Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing / $c Z. Chyra Kufova, T. Sevcikova, J. Januska, P. Vojta, A. Boday, P. Vanickova, J. Filipova, K. Growkova, T. Jelinek, M. Hajduch, R. Hajek,
520    9_
$a AIMS: Amyloidosis is caused by deposition of abnormal protein fibrils, leading to damage of organ function. Hereditary amyloidosis represents a monogenic disease caused by germline mutations in 11 amyloidogenic precursor protein genes. One of the important but non-specific symptoms of amyloidosis is hypertrophic cardiomyopathy. Diagnostics of hereditary amyloidosis is complicated and the real cause can remain overlooked. We aimed to design hereditary amyloidosis gene panel and to introduce new next-generation sequencing (NGS) approach to investigate hereditary amyloidosis in a cohort of patients with hypertrophic cardiomyopathy of unknown significance. METHODS: Design of target enrichment DNA library preparation using Haloplex Custom Kit containing 11 amyloidogenic genes was followed by MiSeq Illumina sequencing and bioinformatics identification of germline variants using tool VarScan in a cohort of 40 patients. RESULTS: We present design of NGS panel for 11 genes (TTR, FGA, APOA1, APOA2, LYZ, GSN, CST3, PRNP, APP, B2M, ITM2B) connected to various forms of amyloidosis. We detected one mutation, which is responsible for hereditary amyloidosis. Some other single nucleotide variants are so far undescribed or rare variants or represent common polymorphisms in European population. CONCLUSIONS: We report one positive case of hereditary amyloidosis in a cohort of patients with hypertrophic cardiomyopathy of unknown significance and set up first panel for NGS in hereditary amyloidosis. This work may facilitate successful implementation of the NGS method by other researchers or clinicians and may improve the diagnostic process after validation.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a familiární amyloidóza $x diagnóza $x genetika $7 D028226
650    _2
$a hypertrofická kardiomyopatie $x diagnóza $x genetika $7 D002312
650    _2
$a výpočetní biologie $7 D019295
650    _2
$a Česká republika $7 D018153
650    _2
$a mutační analýza DNA $x metody $7 D004252
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a stanovení celkové genové exprese $x metody $7 D020869
650    _2
$a frekvence genu $7 D005787
650    _2
$a genetické markery $7 D005819
650    _2
$a genetická predispozice k nemoci $7 D020022
650    12
$a vysoce účinné nukleotidové sekvenování $7 D059014
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a mutace $7 D009154
650    _2
$a fenotyp $7 D010641
650    _2
$a pilotní projekty $7 D010865
650    12
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a rizikové faktory $7 D012307
650    12
$a transkriptom $7 D059467
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sevcikova, Tereza $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Januska, Jaroslav $u Cardiocentre Podlesi, Trinec, Czech Republic.
700    1_
$a Vojta, Petr $u Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacky University, Olomouc, Czech Republic.
700    1_
$a Boday, Arpad $u Laboratory of Molecular Biology, Department of Medical Genetics, Laboratory AGEL, Novy Jicin, Czech Republic.
700    1_
$a Vanickova, Pavla $u Laboratory of Molecular Biology, Department of Medical Genetics, Laboratory AGEL, Novy Jicin, Czech Republic.
700    1_
$a Filipová, Jana $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic. $7 xx0320621
700    1_
$a Growkova, Katerina $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Jelínek, Tomáš, $d 1986- $7 xx0230997 $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Hajduch, Marian $u Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacky University, Olomouc, Czech Republic.
700    1_
$a Hajek, Roman $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
773    0_
$w MED00002597 $t Journal of clinical pathology $x 1472-4146 $g Roč. 71, č. 8 (2018), s. 687-694
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29455155 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20240725141651 $b ABA008
999    __
$a ok $b bmc $g 1340096 $s 1030299
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 71 $c 8 $d 687-694 $e 20180217 $i 1472-4146 $m Journal of clinical pathology $n J Clin Pathol $x MED00002597
GRA    __
$a NV15-29667A $p MZ0
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace